What is the primary role of cyclosporine in kidney transplantation?
A child presents with symptoms suggestive of poisoning, including dry mouth, dilated pupils, difficulty swallowing, delirium, and warm, dry skin. Which class of substance is most likely responsible?
Disulfiram-like interaction with alcohol is seen with all of the following drugs except?
Which of the following drugs is implicated in the causation of osteomalacia?
Which of the following drugs would be removed by dialysis?
What drug is administered for a dystonic reaction induced by metoclopramide?
Pseudojaundice is an adverse effect of which of the following drugs?
Which antitubercular drug causes hepatic adaptation?
Which of the following drugs will not precipitate folate deficiency?
All of the following drugs cause discolouration of urine EXCEPT?
Explanation: **Explanation:** **Cyclosporine** is a potent immunosuppressant and a cornerstone in transplant medicine. Its primary role is the **prevention of graft rejection** (Option C) in solid organ transplants, such as the kidney, liver, and heart. **Mechanism of Action:** Cyclosporine is a **Calcineurin Inhibitor**. It binds to an intracellular protein called **Cyclophilin**. This complex inhibits Calcineurin, a phosphatase required for the dephosphorylation of **NFAT** (Nuclear Factor of Activated T-cells). Without NFAT activation, the transcription of **Interleukin-2 (IL-2)** is blocked. Since IL-2 is the primary cytokine responsible for T-cell proliferation and differentiation, its absence prevents the host’s immune system from attacking the transplanted organ. **Analysis of Incorrect Options:** * **Option A:** Cyclosporine actually *increases* the risk of infection because it suppresses the immune system. * **Option B:** It is an immunosuppressant, not an immunostimulant. * **Option C:** Cyclosporine is notoriously **nephrotoxic** and causes vasoconstriction of the afferent arterioles, which *decreases* renal blood flow rather than enhancing it. **High-Yield Clinical Pearls for NEET-PG:** * **Side Effects (The 5 H’s):** **H**ypertension, **H**irsutism, **H**yperplasia of gums (Gingival hyperplasia), **H**yperlipidemia, and **H**yperkalemia. * **Toxicity:** Nephrotoxicity is the most common dose-limiting side effect. * **Monitoring:** It has a narrow therapeutic index; hence, **Therapeutic Drug Monitoring (TDM)** is mandatory. * **Metabolism:** It is metabolized by **CYP3A4**; drugs like Ketoconazole or Erythromycin can increase its levels, leading to toxicity.
Explanation: ### Explanation The clinical presentation described is the classic **"Anticholinergic Toxidrome,"** resulting from the blockade of muscarinic receptors. The symptoms can be remembered by the famous mnemonic: * **"Blind as a bat"** (Mydriasis/dilated pupils and cycloplegia) * **"Mad as a hatter"** (Delirium, hallucinations, and agitation) * **"Red as a beet"** (Flushing due to vasodilation) * **"Hot as a hare"** (Hyperthermia due to loss of sweating) * **"Dry as a bone"** (Dry mouth/xerostomia and dry skin) **Why the other options are incorrect:** * **Sympathetic agents:** While sympathomimetics (like cocaine or amphetamines) also cause dilated pupils and tachycardia, they typically present with **diaphoresis (profuse sweating)** rather than dry skin. * **Cholinergic agents:** These produce the opposite effect (DUMBELS mnemonic), including miosis (constricted pupils), excessive salivation, lacrimation, and diarrhea. * **Alpha-blockers:** These drugs primarily cause vasodilation leading to hypotension and reflex tachycardia, but they do not cause the constellation of CNS delirium and anticholinergic dryness. **NEET-PG High-Yield Pearls:** 1. **Common Culprits:** Atropine, Datura (stramonium), Belladonna, Tricyclic Antidepressants (TCAs), and first-generation Antihistamines. 2. **Specific Antidote:** **Physostigmine** is the drug of choice for severe central anticholinergic toxicity as it is a tertiary amine that crosses the blood-brain barrier. 3. **Clinical Sign:** "Urinary retention" is another common feature often tested alongside these symptoms.
Explanation: **Explanation:** The **Disulfiram-like reaction** occurs when a drug inhibits the enzyme **Aldehyde Dehydrogenase (ALDH)**. This leads to the accumulation of acetaldehyde in the blood after alcohol consumption, causing symptoms like flushing, tachycardia, palpitations, nausea, and hypotension. **Why Satranidazole is the correct answer:** While most 5-nitroimidazoles (like Metronidazole and Tinidazole) are notorious for causing disulfiram-like reactions, **Satranidazole** is a newer imidazole derivative with a modified side chain. It **does not inhibit aldehyde dehydrogenase** and therefore does not produce a disulfiram-like reaction when taken with alcohol. This makes it a clinically distinct option in the treatment of amoebiasis. **Analysis of incorrect options:** * **Metronidazole:** The classic example of a drug causing this reaction. Patients are strictly advised to avoid alcohol during and for 48 hours after therapy. * **Cefoperazone:** Several cephalosporins containing the **methylthiotetrazole (MTT) side chain** (e.g., Cefoperazone, Cefotetan, Cefamandole) inhibit ALDH and cause this interaction. * **Griseofulvin:** This antifungal agent is well-known to potentiate the effects of alcohol and can trigger a disulfiram-like syndrome in susceptible individuals. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Disulfiram-like drugs:** "**C**an **G**et **M**any **P**roblems **S**oon" (**C**ephalosporins [MTT chain], **G**riseofulvin, **M**etronidazole/Tinidazole, **P**rocarbazine, **S**ulfonylureas [1st Gen like Chlorpropamide]). * **Chlorpropamide** (1st Gen Sulfonylurea) has the highest incidence among antidiabetics. * **Satranidazole** has a longer half-life and better tolerability compared to Metronidazole, specifically lacking the metallic taste and the disulfiram-like potential.
Explanation: **Explanation:** **Phenytoin** is a well-known cause of **osteomalacia** (in adults) and rickets (in children). The primary mechanism involves the induction of hepatic microsomal enzymes (Cytochrome P450). Phenytoin accelerates the metabolism of Vitamin D into inactive metabolites, leading to Vitamin D deficiency. This results in decreased intestinal calcium absorption, secondary hyperparathyroidism, and reduced bone mineralization. Additionally, phenytoin may directly inhibit intestinal calcium transport and interfere with osteoblast function. **Analysis of Incorrect Options:** * **Steroids (Glucocorticoids):** These are the most common cause of drug-induced **osteoporosis**, not osteomalacia. They decrease bone formation by inhibiting osteoblasts and increase bone resorption by osteoclasts. * **Heparin:** Long-term use of unfractionated heparin is associated with **osteoporosis** (by increasing osteoclast activity), but it does not typically cause osteomalacia. * **Estrogen:** Estrogen is actually **bone-protective**. It inhibits bone resorption and is used in the prevention and treatment of postmenopausal osteoporosis. It does not cause osteomalacia. **High-Yield Clinical Pearls for NEET-PG:** * **Other drugs causing Osteomalacia:** Phenobarbital, Carbamazepine (enzyme inducers), and Aluminum-containing antacids (interfere with phosphate absorption). * **Drug-induced Osteoporosis:** Steroids, Heparin, PPIs (long-term), and Aromatase inhibitors (e.g., Letrozole). * **Monitoring:** Patients on long-term Phenytoin therapy should be monitored for serum calcium and Vitamin D levels; prophylactic Vitamin D supplementation is often recommended.
Explanation: **Explanation:** The effectiveness of hemodialysis in removing a drug depends on specific pharmacokinetic properties. For a drug to be "dialyzable," it must have a **low molecular weight**, **low protein binding**, and a **small volume of distribution ($V_d$)** (typically $<1$ L/kg). **Why Salicylates are the correct answer:** Salicylates (Aspirin) have a relatively small $V_d$ (approx. 0.1–0.3 L/kg) and are small molecules. While they are highly protein-bound at therapeutic levels, this binding becomes saturated in toxic doses, leaving more free drug available in the plasma to be filtered across the dialysis membrane. Hemodialysis is the gold standard for severe salicylate poisoning as it corrects acid-base imbalances while rapidly removing the toxin. **Why the other options are incorrect:** * **Digoxin:** It has an extremely large $V_d$ (approx. 5–7 L/kg) because it binds extensively to cardiac and skeletal muscle. Most of the drug is in the tissues, not the blood, making dialysis ineffective. * **Benzodiazepines:** These are highly lipid-soluble with high protein binding and large $V_d$. They are better managed with supportive care or the antagonist Flumazenil. * **Organophosphates:** These compounds bind irreversibly to acetylcholinesterase and redistribute rapidly into adipose tissue. Management focuses on Atropine and Pralidoxime (PAM), not dialysis. **High-Yield NEET-PG Pearls:** * **Mnemonic for Dialyzable drugs (BLAST-M):** **B**arbiturates (Phenobarbital), **L**ithium, **A**lcohols (Methanol/Ethylene glycol), **S**alicylates, **T**heophylline, and **M**etformin. * **Non-dialyzable drugs:** Usually have "D" in their name or class: **D**igoxin, **D**iazepam (Benzos), **D**iphenhydramine (Antihistamines), and **D**erivatives of Opioids. * **Lithium** is the classic example of a drug with very low protein binding that is highly dialyzable.
Explanation: **Explanation:** **Core Concept:** Metoclopramide is a potent **D2 receptor antagonist** used as a prokinetic and antiemetic. By blocking dopamine in the nigrostriatal pathway, it creates a relative **excess of cholinergic activity**, leading to Extrapyramidal Side Effects (EPS), most commonly **Acute Dystonia** (e.g., torticollis, facial grimacing). To treat this, a drug with potent **central anticholinergic** properties must be administered to restore the dopamine-acetylcholine balance. **Why Promethazine is Correct:** **Promethazine** is a first-generation H1-antihistamine that possesses significant **anticholinergic (antimuscarinic)** activity. It effectively crosses the blood-brain barrier to antagonize the excess cholinergic surge caused by metoclopramide, providing rapid relief from dystonic spasms. **Analysis of Incorrect Options:** * **Pheniramine (A):** While it is an antihistamine, its central anticholinergic potency is significantly lower than promethazine, making it less effective for acute dystonia. * **Chlorpromazine (C) & Prochlorperazine (D):** These are antipsychotics that themselves act as **D2 receptor blockers**. Administering them would worsen the dopamine blockade and potentially exacerbate the dystonic reaction. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** The definitive treatment for drug-induced acute dystonia is parenteral **Benztropine** or **Trihexyphenidyl** (centrally acting anticholinergics). Promethazine is the preferred antihistamine alternative. * **Common Culprits:** Metoclopramide, Haloperidol, and Fluphenazine. * **Oculogyric Crisis:** A specific type of dystonia (upward deviation of eyes) frequently associated with metoclopramide in children and young adults. * **Prophylaxis:** Avoid metoclopramide in patients with Parkinson’s disease as it worsens motor symptoms.
Explanation: **Explanation:** **Pseudojaundice** refers to a yellowish-orange discoloration of the skin and mucous membranes without an elevation in serum bilirubin levels. Unlike true jaundice, the sclera is typically spared. **Correct Option: B. Rifabutin** Rifabutin, a rifamycin derivative used primarily in the treatment of *Mycobacterium avium* complex (MAC) and tuberculosis, is known to cause a harmless, reversible yellowish-orange discoloration of the skin, urine, and secretions. This phenomenon is termed **pseudojaundice**. It occurs due to the drug’s inherent pigment and its metabolites. It is important to distinguish this from drug-induced hepatitis, where scleral icterus and elevated liver enzymes would be present. **Incorrect Options:** * **A. Phenytoin:** Known for causing gingival hyperplasia, hirsutism, and Stevens-Johnson Syndrome (SJS), but not pseudojaundice. * **C. Omeprazole:** A Proton Pump Inhibitor (PPI) commonly associated with hypomagnesemia and B12 deficiency; it does not cause skin discoloration. * **D. Chlorpromazine:** This antipsychotic can cause a **blue-gray skin pigmentation** in sun-exposed areas and corneal/lens opacities, but not yellowing. **High-Yield Clinical Pearls for NEET-PG:** * **Other causes of Pseudojaundice:** Excessive intake of Beta-carotene (Carotenemia) and drugs like **Quinacrine**. * **Rifampin vs. Rifabutin:** While both discolor secretions (orange urine), Rifabutin is more specifically linked to the clinical term "pseudojaundice" and **uveitis** (a dose-dependent side effect). * **Scleral Sparing:** The hallmark of pseudojaundice is that the **sclera remains white**, whereas in true jaundice (icterus), the sclera is the first site to turn yellow due to high elastin content's affinity for bilirubin.
Explanation: ### Explanation **Correct Option: A (Isoniazid)** Hepatic adaptation refers to a transient, asymptomatic rise in serum transaminases (AST/ALT) that occurs in approximately 10–20% of patients starting **Isoniazid (INH)**. This is a self-limiting phenomenon where the liver enzymes increase (usually <3 times the upper limit of normal) and then return to baseline even while the drug is continued. It represents a physiological adjustment of the liver to the drug metabolites rather than true hepatotoxicity. True INH-induced hepatitis is much rarer (1%) and requires drug discontinuation. **Analysis of Incorrect Options:** * **B. Rifampicin:** While Rifampicin is a potent inducer of microsomal enzymes and can cause dose-dependent cholestatic jaundice, it does not typically cause the specific "adaptation" phenomenon associated with INH. When used with INH, it increases the risk of hepatotoxicity by inducing enzymes that produce toxic metabolites. * **C. Pyrazinamide:** This is the **most hepatotoxic** drug among the first-line ATT. It causes dose-related hepatotoxicity and does not show a benign "adaptation" phase; any significant rise in enzymes usually necessitates immediate cessation. * **D. Ethambutol:** This drug is primarily excreted by the kidneys and is **not hepatotoxic**. Its primary side effect is optic neuritis (retrobulbar neuritis). **NEET-PG High-Yield Pearls:** * **Most Hepatotoxic ATT:** Pyrazinamide > Isoniazid > Rifampicin. * **Least Hepatotoxic/Safe in Liver Disease:** Ethambutol and Streptomycin. * **INH Toxicity:** Associated with peripheral neuropathy (prevented by Pyridoxine/Vit B6) and Sideroblastic anemia. * **Clinical Rule:** Stop ATT if Transaminases are >3 times normal with symptoms (nausea, jaundice) or >5 times normal if asymptomatic.
Explanation: Folate deficiency is a common side effect of several drug classes, typically occurring through mechanisms such as impaired absorption, inhibition of the dihydrofolate reductase (DHFR) enzyme, or increased metabolic breakdown. **Why Chloroquine is the correct answer:** Chloroquine is an antimalarial and DMARD that does not interfere with folic acid metabolism or absorption [2]. Unlike its counterpart **Pyrimethamine** (which inhibits DHFR) [1, 3], Chloroquine acts by inhibiting heme polymerase in plasmodia [2]. Therefore, it does not precipitate megaloblastic anemia or folate deficiency. **Analysis of Incorrect Options:** * **Alcohol:** Chronic alcohol consumption is a leading cause of folate deficiency. It interferes with the enterohepatic circulation of folate, inhibits intestinal absorption, and impairs the liver's ability to store the vitamin [4]. * **Sulfasalazine:** Used in inflammatory bowel disease, this drug inhibits the intestinal mucosal uptake of folate, leading to decreased serum levels. Patients on long-term therapy often require folate supplementation. * **Phenytoin:** This anticonvulsant reduces folate levels by inhibiting intestinal conjugase enzymes (preventing the breakdown of polyglutamates to absorbable monoglutamates) and by inducing hepatic enzymes that increase folate catabolism. **NEET-PG High-Yield Pearls:** * **DHFR Inhibitors:** Methotrexate, Trimethoprim, and Pyrimethamine [1, 3] are the most "classic" causes of drug-induced folate deficiency. * **Antiepileptics:** Besides Phenytoin, Phenobarbital and Primidone can also cause folate deficiency. * **Clinical Sign:** Drug-induced folate deficiency presents as **Megaloblastic Anemia** without neurological symptoms (distinguishing it from Vitamin B12 deficiency). * **Pregnancy:** Always remember that drugs interfering with folate (like Valproate or Carbamazepine) increase the risk of **Neural Tube Defects**.
Explanation: **Explanation:** The correct answer is **Digoxin**. Digoxin is a cardiac glycoside used in heart failure and atrial fibrillation. It is not known to cause any change in urine color. However, it is high-yield to remember that Digoxin toxicity can cause **visual disturbances**, specifically **xanthopsia** (yellow-green halos around lights). **Analysis of Options:** * **Nitrofurantoin:** This urinary antiseptic commonly causes the urine to turn **brown or dark orange**. This is a harmless side effect but important for patient counseling. * **Azo dyes (e.g., Phenazopyridine):** Used as urinary analgesics, these dyes characteristically turn urine a **bright orange to red** color. They can also stain contact lenses. * **Rifampicin:** A key anti-tubercular drug and a potent enzyme inducer. It causes a classic **orange-red discoloration** of urine, sweat, tears, and saliva. **NEET-PG High-Yield Clinical Pearls:** * **Red/Orange Urine:** Rifampicin, Phenazopyridine, Anthraquinones (Senna), Doxorubicin. * **Black/Dark Brown Urine:** Nitrofurantoin, L-Dopa, Methyldopa, Alkaptonuria (on standing), Chloroquine. * **Blue/Green Urine:** Amitriptyline, Methylene blue, Propofol, Triamterene. * **Digoxin Toxicity:** Look for the triad of GI symptoms (nausea/vomiting), neurological symptoms (confusion), and visual changes (yellow vision). The most specific ECG finding is the "reverse tick" sign (ST-segment depression).
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free